October 2018 Volume 14, Issue 10
Volume 14, Issue 10 | October 2018
October 2018
In this Issue
Discovery
A new answer for amoeba treatment
Skaggs researchers from UCSD repurpose approved drugs to treat fatal brain infectionSay yes to YRSACT
Scripps scientists find new lead to combat low platelet countsInfectious disease research reaches across borders
New collaboration announced between Boehringer Ingelheim and Tsinghua UniversityGetting together
A roundup of recent discovery-related deals and agreementsAI, drug discovery and rare disease
Pharma executive Kate Hilyard joins Healx to drive integration effort forwardResearch & Development
Transcription factors and TransSyn
Multicenter European team reveals computational method for predicting how to convert subpopulations of cellsAll in the epigenetics
Team finds epigenetic reason for drug resistance in deadly melanoma and identifies potential ways to counteract itBispecific boon
Aptevo will use Genedata platform to streamline cancer immunotherapy R&DMore than just skin
Otezla post-hoc sub-analyses showed meaningful improvements in metrics beyond skin clearanceWelcome to the real world
PAREXEL and Datavant partner to enhance drug development and commercializationSpecial Reports
Special Report on Cell Biology: Well CHOsen?
Ever more complicated biologics push technical boundariesEditor's Focus
Editor’s focus: The struggle against schizophrenia
Therapeutics for mental illness have always been tricky, but schizophrenia seems a bit more intractable than mostCommentary
New recruits for 2019
Opportunities for Ph.D. students entering the workforce go beyond just academiaGuest Commentary: Bringing precision medicine to the evaluation and treatment of mental illness
What we do know about the genetics, neurobiology and behavioral science of mental illness can be used to improve diagnosis and treatmentFeature
Society for Neuroscience Annual Meeting Show Preview: Taking notice of the neurological
SfN annual meeting gets ready for networking, the most recent neurological research and the newest neuroscienceFocus Feature on Breast Cancer
Beginning with a story about Salk researchers finding a ‘master control switch' for aggressive breast cancer, we give you a quick roundup of recent breast cancer news in honor of Breast Cancer Awareness MonthPreclinical
Possibility grows for pan-Ebola vaccine
Scripps team discovers potential target mechanisms that could enable the treatment of multiple strains of EbolavirusMore coverage on Coversin
Akari reports on the effects of its bimodal Coversin in inflammatory indicationsFR104 offers control of graft-versus-host disease
OSE Immunotherapeutics’ study of the CD28 antagonist was published in Journal of Clinical InvestigationPeering into the preclinical realm
A roundup of recent preclinical data presentations and journal publicationsClinical Trials
Effective option for the skin
Clinical trial shows monoclonal antibody drug effective against pruritusDupixent delivers strong Phase 3 results
Patients saw improvements in skin clearing and quality of lifeOut of the starting gate
A roundup of clinical trial startups and initial breakthroughsDiagnostics
Diagenode snaps up NXT-Dx
The transaction expands Diagenode’s epigenetics and epigenomics offerings‘A clear benefit’
Agena, PerkinElmer partnership emphasizes quality, speed and sensitivity in liquid biopsyIt’s all in the volume measurement
Data show Daxor’s BVA-100 is superior to formula-based estimates of blood volume in assessing heart failure patientsA ‘breakthrough biomarker’ for rheumatoid arthritis
Novel test now available to aid in detection and management of debilitating conditionContract Services
Partnering for efficiency
Companies collaborate on cloud-based IT validation software for life sciencesBuilding better models
CrownBio licenses translational breast cancer models of resistance and metastasisExtending the value
CRO announces $7.8M extension agreement for OmniComm’s TrialOneBusiness & Government Policy
Boehringer Ingelheim acquires all ViraTherapeutics shares
The German company seeks to develop next-generation viral-based immuno-oncology therapiesBIA Separations expands
New lab processing facility will support integrated optimization of upstream and downstream process developmentOn the cutting edge
A roundup of instrumentation, software and other tools and technology news
